Intratumoral androgen biosynthesis in prostate cancer pathogenesis and response to therapy

C Cai, SP Balk - Endocrine-related cancer, 2011 - erc.bioscientifica.com
The majority of prostate cancers (PCa) express high levels of androgen receptor (AR) and
are dependent for their growth on testosterone produced by the testes, which is reduced in …

Cancer chemoprevention.

SM Lippman, SE Benner, WK Hong - Journal of Clinical Oncology, 1994 - ascopubs.org
PURPOSE To review the most important recent advances in clinical trials and biologic
studies within the growing field of chemoprevention. METHODS The most critical methods …

[PDF][PDF] The molecular taxonomy of primary prostate cancer

A Abeshouse, J Ahn, R Akbani, A Ally, S Amin… - Cell, 2015 - cell.com
There is substantial heterogeneity among primary prostate cancers, evident in the spectrum
of molecular abnormalities and its variable clinical course. As part of The Cancer Genome …

Molecular classification of prostate cancer progression: foundation for marker-driven treatment of prostate cancer

CJ Logothetis, GE Gallick, SN Maity, J Kim, A Aparicio… - Cancer discovery, 2013 - AACR
Recently, many therapeutic agents for prostate cancer have been approved that target the
androgen receptor and/or the prostate tumor microenvironment. Each of these therapies has …

Activation of the androgen receptor by intratumoral bioconversion of androstanediol to dihydrotestosterone in prostate cancer

JL Mohler, MA Titus, S Bai, BJ Kennerley, FB Lih… - Cancer research, 2011 - AACR
The androgen receptor (AR) mediates the growth of benign and malignant prostate in
response to dihydrotestosterone (DHT). In patients undergoing androgen deprivation …

Elimination of the male reproductive tract in the female embryo is promoted by COUP-TFII in mice

F Zhao, HL Franco, KF Rodriguez, PR Brown, MJ Tsai… - Science, 2017 - science.org
The sexual differentiation paradigm contends that the female pattern of the reproductive
system is established by default because the male reproductive tracts (Wolffian ducts) in the …

[HTML][HTML] The mechanism of the cytotoxic effect of Panax notoginseng extracts on prostate cancer cells

B Hawthorne, K Lund, S Freggiaro, R Kaga… - Biomedicine & …, 2022 - Elsevier
Abstract Introduction Panax notoginseng (Burkill) FH commonly referred to as Sanqi, is a
Chinese herb that has long been used to treat various conditions including blood disorders …

[HTML][HTML] Drug repurposing approach, potential drugs, and novel drug targets for COVID-19 treatment

ZD Kifle, AG Ayele, EF Enyew - Journal of Environmental and Public …, 2021 - hindawi.com
Novel coronavirus first appeared in Wuhan, China, in December 2019, and it speedily
expanded globally. Some medications which are used to treat other diseases seem to be …

Repurposing existing drugs for COVID-19: an endocrinology perspective

FA Cadegiani - BMC endocrine disorders, 2020 - Springer
Abstract Background Coronavirus Disease 2019 (COVID-19) is a multi-systemic infection
caused by the novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), that …

Targeted androgen pathway suppression in localized prostate cancer: a pilot study

EA Mostaghel, PS Nelson, P Lange, DW Lin… - Journal of Clinical …, 2014 - ascopubs.org
Purpose Ligand-mediated activation of the androgen receptor (AR) is critical for prostate
cancer (PCa) survival and proliferation. The failure to completely ablate tissue androgens …